deploy: abafb0e

index.xml

@@ -49,8 +49,8 @@ Developmental Research Project Awards Funding Opportunity Title
 AI-driven Structure-enabled Antiviral Platform (ASAP) Discovery Consortium Developmental Project Award Program</description></item><item><title>Developmental and Mentored Awards</title><link>https://asapdiscovery.org/awards/projects/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://asapdiscovery.org/awards/projects/</guid><description>Developmental Research Projects Applications for the ASAP AViDD Center Developmental Research Project Awards and Mentored Project Awards closed on 13 Jan 2023. After scoring applications by our Scientific Advisory Board, NIAID approved the following awards, which were issued on 1 May 2023.
 Funds for these awards are provided by the National Institutes of Health under award number U19AI171399 through the NIAID Antiviral Drug Discovery (AViDD) U19 Program.
 Defining mutational constraints of ASAP-prioritized SARS-CoV-2 target proteins via multiplexed, yeast-based cDNA Project Leader: Farren Isaacs, Yale University, New Haven, CT</description></item><item><title>FAQ</title><link>https://asapdiscovery.org/privacy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://asapdiscovery.org/privacy/</guid><description>ASAP Discovery Consortium Privacy Policy This Privacy Policy explains how ASAP Discovery Consortium (&amp;ldquo;we,&amp;rdquo; &amp;ldquo;us,&amp;rdquo; or &amp;ldquo;our&amp;rdquo;) collects, uses, and safeguards your personal information when you visit our website and interact with our services. We are committed to protecting your privacy and complying with applicable data protection laws, including the General Data Protection Regulation (GDPR).
-By using the ASAP Discovery Consortium website and services, you consent to the terms outlined in this Privacy Policy.</description></item><item><title>Open Science</title><link>https://asapdiscovery.org/open-science/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://asapdiscovery.org/open-science/</guid><description>April 2023
-Authors: Pascale Boulet, ASAP IP Strategy Consultant, Intellectual Property &amp;amp; Access Leader, DNDi
+By using the ASAP Discovery Consortium website and services, you consent to the terms outlined in this Privacy Policy.</description></item><item><title>Open Science</title><link>https://asapdiscovery.org/open-science/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://asapdiscovery.org/open-science/</guid><description>Authors: Pascale Boulet, ASAP IP Strategy Consultant, Intellectual Property &amp;amp; Access Leader, DNDi
 Dr Ed Griffen, ASAP Lead Optimization Project Lead, MedChemica Consultancy Ltd
-Antivirals must be globally accessible to be effective against pandemics ASAP accelerates open science antiviral drug discovery to deliver oral antivirals for pandemics with the goal of global, equitable, and affordable access.
-Nobody is safe unless everybody is safe. Modern air travel means infectious agents can spread easily across the globe.</description></item></channel></rss>
+Our approach to open science and intellectual property is described in detail in this journal article preprint:
+Griffen, E., &amp;amp; Boulet, P. (2024). ASAP Policy on Intellectual Property Management and Open Science Disclosure (1.0). Zenodo. https://doi.org/10.5281/zenodo.12191567
+Below, we provide a summary of the main principles of our approach to open science:</description></item></channel></rss>